Jason Valent, MD of Cleveland Clinic discusses the 5 year outlook of plasma cell therapy in multiple myeloma at the 58th ASH Annual Meeting in San Diego, CA.
Plasma Cell Therapy: 5 Year Outlook
Jason Valent, MD of Cleveland Clinic discusses the 5 year outlook of plasma cell therapy in multiple myeloma at the 58th ASH Annual Meeting in San Diego, CA.